Reducing treatment related distress in children with leukaemia

Not Applicable

Completed

• Conditions: ational Cancer Research Network: Paediatric Oncology, Disease: Leukaemia (acute), Leukaemia (acute myeloid), Leukaemia (acute lymphoblastic), Paediatrics; Cancer; Acute lymphoblastic, acute myeloid leukaemia

• Registration Number: ISRCTN36769062
• Lead Sponsor: Central Manchester University Hospitals NHS Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-10-20
• Study Completion: 2013-01-01
• Last Update Posted: 19 April 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

1. Patients aged between 7 and 12 years
2. Treated for leukaemia at Royal Manchester Children's Hospital
3. Parents must be able to receive and understand verbal and written information about the study and give written informed consent
4. Male and female participants

Exclusion Criteria

1. Age under 7 or over 12 years
2. Other types of maligant disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Quality of life<br> 2. Emotional and behavioural functioning<br><br> Theses are measured immediately before, immediately after intervention, at 12 weeks and at 6 months<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Caregiving burden<br> 2. Ffear of medical procedure<br> 3. Self-efficacy<br><br> These are measured immediately before, immediately after intervention, at 12 weeks and at 6 months.<br>